1. Alimena G, Morra E, Lazzarino M, Liberati AM, Montefusco E, Inverardi D, Bernasconi P, Mancini M, Donti E, Grignani F (1990) Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemia. Eur J Haematol Suppl 52:25–28
2. Allan NC, Richards SM, Shepherd PC, on behalf of the UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia (1995) UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. Lancet 345(8962):1392–1397
3. Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C (1994) Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist. Blood 84(12):4142–4150
4. Aman MJ, Bug G, Aulitzky WE, Huber C, Peschel C (1996) Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells. Exp Hematol 24(8):863–867
5. Andrews DF 3rd, Singer JW, Collins SJ (1987) Effect of recombinant α-interferon on the expression of the bcr-abl fusion gene in human chronic myelogenous human leukemia cell lines. Cancer Res 47(24 Pt 1):6629–6632